NICE Recommends Durvalumab for Lung Cancer Patients – Medscape

Written by

admin

in

  1. NICE Recommends Durvalumab for Lung Cancer Patients  Medscape
  2. NICE recommends first immunotherapy for limited-stage small cell lung cancer  The Pharmaceutical Journal
  3. Targeted drug that extends the life of people with lung cancer approved for NHS  lbc.co.uk
  4. Imfinzi approved for NHS use in limited-stage small cell lung cancer  PharmaTimes
  5. National Institute for Health and Clinical Excellence (NICE)  Wired-Gov

Continue Reading

More posts